Net profit of Bal Pharma rose 225.00% to Rs 0.26 crore in the quarter ended June 2024 as against Rs 0.08 crore during the previous quarter ended June 2023. Sales rose 5.64% to Rs 74.36 crore in the quarter ended June 2024 as against Rs 70.39 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended | ||
| Jun. 2024 | Jun. 2023 | % Var. | |
| Sales | 74.36 | 70.39 | 6 |
| OPM % | 8.69 | 9.15 | - |
| PBDT | 3.05 | 2.96 | 3 |
| PBT | 0.62 | 0.43 | 44 |
| NP | 0.26 | 0.08 | 225 |
Why Gold Remains a Safe Haven Amid Global Economic Shifts in 2025
4 mins read . Sep 5, 2025
Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025
3 mins read . Aug 20, 2025
What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025
8 mins read . Aug 18, 2025
Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
Recent Article
- •
- •
- •
- •
